US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.6408

-0.0403-5.92%

Volume:888.54K

Turnover:574.00K

Market Cap:33.64M

PE:-0.57

High:0.6977

Open:0.6900

Low:0.6380

Close:0.6811

52wk High:1.70

52wk Low:0.6150

Shares:52.50M

Float Shares:23.43M

Volume Ratio:1.97

T/O Rate:3.79%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1285

EPS(LYR):-1.0884

ROE:-908.28%

ROA:-26.26%

PB:-4.16

PE(LYR):-0.59

Loading ...

Overview Company News Filings

Xilio Therapeutics - Transfers Listing of Co's Common Stock to Nasdaq Capital Market,Effective October 6 - SEC Filing

THOMSON REUTERS

Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance

BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License Deal

Xilio Therapeutics Extends Cash Runway into Q1 2027 Following $17.5 Million Milestone Achievement

Xilio Therapeutics Inc. Faces Nasdaq Delisting Risk Due to Stockholders' Equity and Minimum Bid Price Non-Compliance

Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million

Xilio Therapeutics Reports Q2 2025 Results: Collaboration and License Revenue Surges to $8.1M; Net Loss Widens to $15.8M

Xilio Therapeutics Inc: on Track to Nominate First Development Candidates for Wholly Owned Masked T Cell Engager Programs in H2 2025

THOMSON REUTERS

Xilio Therapeutics Initiated at Outperform by Leerink Partners

Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target

MT Newswires Live

Catalyst Pharmaceuticals Appoints Daniel Curran, Md, to Its Board of Directors

THOMSON REUTERS

Xilio Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Xilio Therapeutics Unveils New Stock Option Grants for Employees Under 2022 Inducement Plan

Director Shannon James Samuel Reports Acquisition of Common Shares in Xilio Therapeutics Inc

Rene Russo, President and CEO, Reports Acquisition of Common Shares in Xilio Therapeutics Inc

Xilio Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Bello Akintunde Olatokumbo

Xilio Therapeutics Inc. Held Annual Stockholders Meeting

Xilio Therapeutics Appoints Dr. Akintunde Bello to Board of Directors, Enhancing Leadership in Cancer Immunotherapy Development

Xilio Therapeutics Announces New Stock Option Grants for Employees Under 2022 Inducement Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","market":"US","secType":"STK","nameCN":"XILIO THERAPEUTICS, INC.","latestPrice":0.6408,"timestamp":1765823549936,"preClose":0.6811,"halted":0,"volume":888537,"delay":0,"floatShares":23433834,"shares":52500328,"eps":-1.128499,"marketStatus":"Trading","change":-0.0403,"latestTime":"12-15 13:32:34 EST","open":0.69,"high":0.6977,"low":0.638,"amount":574003.39641372,"amplitude":0.087652,"askPrice":0.6416,"askSize":932,"bidPrice":0.64,"bidSize":215,"shortable":3,"etf":0,"ttmEps":-1.128499,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1634875200000,"exchange":"NASDAQ","adjPreClose":0.6811,"preHourTrading":{"tag":"盘前","latestPrice":0.6995,"preClose":0.6811,"latestTime":"09:24 EST","volume":618,"amount":430.3645086,"timestamp":1765808679773},"postHourTrading":{"tag":"盘后","latestPrice":0.6834,"preClose":0.6811,"latestTime":"19:14 EST","volume":14024,"amount":9751.4577,"timestamp":1765584849190},"volumeRatio":1.96848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","floatShares":23433834,"roa":"-26.26%","roe":"-908.28%","lyrEps":-1.088384,"volumeRatio":1.96848,"shares":52500328,"dividePrice":0,"high":0.6977,"amplitude":0.087652,"preClose":0.6811,"low":0.638,"week52Low":0.615,"pbRate":"-4.16","psRate":"1.06","week52High":1.7,"institutionHeld":0,"latestPrice":0.6408,"committee":-0.625109,"eps":-1.128499,"divideRate":0,"volume":888537,"delay":0,"ttmEps":-1.128499,"open":0.69,"prevYearClose":0.955,"prevWeekClose":0.6811,"prevMonthClose":0.7576,"prevQuarterClose":0.8427,"fiveDayClose":0.73,"twentyDayClose":0.7072,"sixtyDayClose":0.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"XLO","fiscalQuarterEnding":"2025/09","expectedEps":-0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2025-08-14","symbol":"XLO","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-05-08","symbol":"XLO","fiscalQuarterEnding":"2025/03","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-11","symbol":"XLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-07","symbol":"XLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1754456400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XLO","date":"2025-12-12","current":-0.567834,"percent":0.722441,"low":-8.819798,"twenty":-1.010305,"median":-0.752358,"eighty":-0.571566,"high":-0.169617,"avg":-1.205876,"sd":1.455128,"marketCap":37290982},"quantilePoints":[{"date":"2021-10-22","current":-5.619943,"twenty":-5.655644,"median":-5.655644,"eighty":-5.634223,"marketCap":423962880},{"date":"2021-10-29","current":-5.897428,"twenty":-5.742879,"median":-5.655644,"eighty":-5.632588,"marketCap":444896047},{"date":"2021-11-05","current":-7.534236,"twenty":-7.275719,"median":-5.778004,"eighty":-5.653191,"marketCap":568375236},{"date":"2021-11-12","current":-7.783621,"twenty":-8.139785,"median":-6.784325,"eighty":-5.655644,"marketCap":587188588},{"date":"2021-11-19","current":-7.994369,"twenty":-8.332268,"median":-7.783621,"eighty":-5.669463,"marketCap":603087196},{"date":"2021-11-26","current":-6.993317,"twenty":-8.285904,"median":-7.699322,"eighty":-5.707754,"marketCap":527568808},{"date":"2021-12-03","current":-4.59754,"twenty":-8.14962,"median":-7.070591,"eighty":-5.652373,"marketCap":353417461},{"date":"2021-12-10","current":-3.644608,"twenty":-8.092015,"median":-6.680707,"eighty":-5.383906,"marketCap":280164654},{"date":"2021-12-17","current":-3.769058,"twenty":-8.017551,"median":-5.735855,"eighty":-4.164453,"marketCap":289731252},{"date":"2021-12-23","current":-5.689144,"twenty":-8.011931,"median":-5.689668,"eighty":-4.138852,"marketCap":437330192},{"date":"2021-12-31","current":-5.689144,"twenty":-7.994369,"median":-5.689144,"eighty":-4.156631,"marketCap":437330192},{"date":"2022-01-07","current":-5.091784,"twenty":-7.797671,"median":-5.658171,"eighty":-4.266858,"marketCap":391410521},{"date":"2022-01-14","current":-5.162898,"twenty":-7.783621,"median":-5.653587,"eighty":-4.59754,"marketCap":396877149},{"date":"2022-01-21","current":-4.842884,"twenty":-7.716182,"median":-5.64292,"eighty":-4.788126,"marketCap":372277325},{"date":"2022-01-28","current":-4.77177,"twenty":-7.567253,"median":-5.591843,"eighty":-4.822972,"marketCap":366810698},{"date":"2022-02-04","current":-3.598384,"twenty":-7.225139,"median":-5.49358,"eighty":-4.4546,"marketCap":276611346},{"date":"2022-02-11","current":-4.739768,"twenty":-7.024227,"median":-5.32737,"eighty":-4.153075,"marketCap":364350716},{"date":"2022-02-18","current":-4.82155,"twenty":-6.909018,"median":-5.17001,"eighty":-4.244813,"marketCap":370637337},{"date":"2022-02-25","current":-4.675765,"twenty":-6.763601,"median":-5.152231,"eighty":-4.222767,"marketCap":359430751},{"date":"2022-03-04","current":-3.096766,"twenty":-6.21074,"median":-5.107785,"eighty":-4.106851,"marketCap":234734857},{"date":"2022-03-11","current":-2.663652,"twenty":-5.825774,"median":-5.088228,"eighty":-3.781858,"marketCap":201904807},{"date":"2022-03-18","current":-2.77554,"twenty":-5.735355,"median":-5.013559,"eighty":-3.685854,"marketCap":210385903},{"date":"2022-03-25","current":-2.526499,"twenty":-5.698992,"median":-4.963778,"eighty":-3.539359,"marketCap":191508625},{"date":"2022-04-01","current":-2.475969,"twenty":-5.691597,"median":-4.880219,"eighty":-3.443152,"marketCap":187678452},{"date":"2022-04-08","current":-2.537327,"twenty":-5.689563,"median":-4.835772,"eighty":-3.159567,"marketCap":192329376},{"date":"2022-04-14","current":-2.180008,"twenty":-5.689144,"median":-4.77177,"eighty":-2.747387,"marketCap":165244585},{"date":"2022-04-22","current":-1.454542,"twenty":-5.689144,"median":-4.707766,"eighty":-2.648493,"marketCap":110254251},{"date":"2022-04-29","current":-1.27492,"twenty":-5.677766,"median":-4.57265,"eighty":-2.569089,"marketCap":96638949},{"date":"2022-05-06","current":-1.311037,"twenty":-5.658676,"median":-4.385974,"eighty":-2.547433,"marketCap":99376596},{"date":"2022-05-13","current":-1.14627,"twenty":-5.655644,"median":-4.188632,"eighty":-2.530108,"marketCap":92258714},{"date":"2022-05-20","current":-0.816335,"twenty":-5.654821,"median":-4.133519,"eighty":-2.502678,"marketCap":65703535},{"date":"2022-05-27","current":-1.102052,"twenty":-5.652774,"median":-3.930511,"eighty":-2.265187,"marketCap":88699772},{"date":"2022-06-03","current":-0.945588,"twenty":-5.649828,"median":-3.790392,"eighty":-1.806807,"marketCap":76106594},{"date":"2022-06-10","current":-1.017017,"twenty":-5.638325,"median":-3.710388,"eighty":-1.458346,"marketCap":81855654},{"date":"2022-06-17","current":-0.70749,"twenty":-5.619943,"median":-3.662386,"eighty":-1.354377,"marketCap":56943063},{"date":"2022-06-24","current":-0.812934,"twenty":-5.619943,"median":-3.598384,"eighty":-1.267697,"marketCap":65429770},{"date":"2022-07-01","current":-0.979602,"twenty":-5.563744,"median":-3.523713,"eighty":-1.159876,"marketCap":78844242},{"date":"2022-07-08","current":-1.17008,"twenty":-5.533214,"median":-3.456155,"eighty":-1.140148,"marketCap":94175067},{"date":"2022-07-15","current":-1.037426,"twenty":-5.49998,"median":-3.32776,"eighty":-1.085725,"marketCap":83498242},{"date":"2022-07-22","current":-1.057834,"twenty":-5.470823,"median":-3.149101,"eighty":-1.083005,"marketCap":85140831},{"date":"2022-07-29","current":-0.986405,"twenty":-5.364184,"median":-2.77554,"eighty":-1.046269,"marketCap":79391771},{"date":"2022-08-05","current":-1.102052,"twenty":-5.320424,"median":-2.696136,"eighty":-1.036746,"marketCap":88699772},{"date":"2022-08-12","current":-0.822578,"twenty":-5.273125,"median":-2.638387,"eighty":-1.029943,"marketCap":67383911},{"date":"2022-08-19","current":-0.792483,"twenty":-5.1885,"median":-2.582443,"eighty":-1.019739,"marketCap":64918646},{"date":"2022-08-26","current":-0.752358,"twenty":-5.16432,"median":-2.558983,"eighty":-0.995929,"marketCap":61631626},{"date":"2022-09-02","current":-0.692169,"twenty":-5.154364,"median":-2.548154,"eighty":-0.989126,"marketCap":56701096},{"date":"2022-09-09","current":-0.919548,"twenty":-5.147964,"median":-2.539131,"eighty":-0.97416,"marketCap":75327543},{"date":"2022-09-16","current":-1.003143,"twenty":-5.130186,"median":-2.530108,"eighty":-0.962595,"marketCap":82175502},{"date":"2022-09-23","current":-1.003143,"twenty":-5.105296,"median":-2.513866,"eighty":-0.964636,"marketCap":82175502},{"date":"2022-09-30","current":-0.973049,"twenty":-5.093206,"median":-2.475969,"eighty":-0.964636,"marketCap":79710236},{"date":"2022-10-07","current":-0.916204,"twenty":-5.08965,"median":-2.286481,"eighty":-0.962595,"marketCap":75053625},{"date":"2022-10-14","current":-0.769077,"twenty":-5.06476,"median":-1.858781,"eighty":-0.94028,"marketCap":63001218},{"date":"2022-10-21","current":-0.728951,"twenty":-5.046982,"median":-1.5525,"eighty":-0.91821,"marketCap":59714198},{"date":"2022-10-28","current":-0.782452,"twenty":-5.007158,"median":-1.454542,"eighty":-0.886404,"marketCap":64096891},{"date":"2022-11-04","current":-0.765733,"twenty":-4.979423,"median":-1.388688,"eighty":-0.850349,"marketCap":62727299},{"date":"2022-11-11","current":-0.800435,"twenty":-4.969467,"median":-1.311037,"eighty":-0.824584,"marketCap":68402762},{"date":"2022-11-18","current":-0.830646,"twenty":-4.957378,"median":-1.265891,"eighty":-0.82124,"marketCap":70984515},{"date":"2022-11-25","current":-0.849568,"twenty":-4.938888,"median":-1.206298,"eighty":-0.820572,"marketCap":72601537},{"date":"2022-12-02","current":-0.779332,"twenty":-4.887686,"median":-1.17008,"eighty":-0.816068,"marketCap":66599372},{"date":"2022-12-09","current":-0.737639,"twenty":-4.841462,"median":-1.144569,"eighty":-0.808598,"marketCap":63036442},{"date":"2022-12-16","current":-0.750468,"twenty":-4.837906,"median":-1.129263,"eighty":-0.802075,"marketCap":64132728},{"date":"2022-12-23","current":-0.753675,"twenty":-4.830083,"median":-1.115833,"eighty":-0.793821,"marketCap":64406800},{"date":"2022-12-30","current":-0.862717,"twenty":-4.811594,"median":-1.102052,"eighty":-0.792483,"marketCap":73725230},{"date":"2023-01-06","current":-0.871537,"twenty":-4.77177,"median":-1.090148,"eighty":-0.792483,"marketCap":74478927},{"date":"2023-01-13","current":-0.853096,"twenty":-4.74688,"median":-1.061235,"eighty":-0.792483,"marketCap":72903016},{"date":"2023-01-20","current":-0.894789,"twenty":-4.74119,"median":-1.053301,"eighty":-0.795158,"marketCap":76465945},{"date":"2023-01-27","current":-1.372651,"twenty":-4.688566,"median":-1.055567,"eighty":-0.795827,"marketCap":117302597},{"date":"2023-02-03","current":-1.16098,"twenty":-4.613185,"median":-1.081644,"eighty":-0.799513,"marketCap":99213879},{"date":"2023-02-10","current":-0.962138,"twenty":-4.577628,"median":-1.082826,"eighty":-0.801513,"marketCap":82221447},{"date":"2023-02-17","current":-1.148152,"twenty":-4.515758,"median":-1.061235,"eighty":-0.802368,"marketCap":98117593},{"date":"2023-02-24","current":-1.122495,"twenty":-4.501535,"median":-1.084009,"eighty":-0.802643,"marketCap":95925021},{"date":"2023-03-03","current":-0.945045,"twenty":-4.362862,"median":-1.082826,"eighty":-0.804607,"marketCap":83373763},{"date":"2023-03-10","current":-0.864219,"twenty":-4.26828,"median":-1.057834,"eighty":-0.807261,"marketCap":76243112},{"date":"2023-03-17","current":-0.913958,"twenty":-4.219922,"median":-1.04933,"eighty":-0.8088,"marketCap":80631205},{"date":"2023-03-24","current":-0.95748,"twenty":-4.169431,"median":-1.040827,"eighty":-0.809202,"marketCap":84470786},{"date":"2023-03-31","current":-0.985458,"twenty":-4.145964,"median":-1.035725,"eighty":-0.811441,"marketCap":86939088},{"date":"2023-04-06","current":-0.935719,"twenty":-4.134585,"median":-1.030623,"eighty":-0.814116,"marketCap":82550995},{"date":"2023-04-14","current":-1.032089,"twenty":-4.106851,"median":-1.030623,"eighty":-0.816068,"marketCap":91052925},{"date":"2023-04-21","current":-0.917067,"twenty":-4.017114,"median":-1.026546,"eighty":-0.816335,"marketCap":80905461},{"date":"2023-04-28","current":-0.948646,"twenty":-3.911443,"median":-1.02382,"eighty":-0.817495,"marketCap":83691451},{"date":"2023-05-05","current":-0.911322,"twenty":-3.845861,"median":-1.021746,"eighty":-0.820572,"marketCap":80398672},{"date":"2023-05-12","current":-0.980924,"twenty":-3.781858,"median":-1.017017,"eighty":-0.823915,"marketCap":87807424},{"date":"2023-05-19","current":-0.962532,"twenty":-3.746301,"median":-1.012271,"eighty":-0.827811,"marketCap":86161034},{"date":"2023-05-26","current":-0.94108,"twenty":-3.710744,"median":-1.010214,"eighty":-0.834494,"marketCap":84240763},{"date":"2023-06-02","current":-0.892033,"twenty":-3.707189,"median":-1.007219,"eighty":-0.840742,"marketCap":79850365},{"date":"2023-06-09","current":-0.921155,"twenty":-3.693676,"median":-1.004815,"eighty":-0.843978,"marketCap":82457163},{"date":"2023-06-16","current":-0.836856,"twenty":-3.65883,"median":-1.003143,"eighty":-0.837538,"marketCap":74911167},{"date":"2023-06-23","current":-0.833791,"twenty":-3.644608,"median":-0.99838,"eighty":-0.836856,"marketCap":74636767},{"date":"2023-06-30","current":-0.82766,"twenty":-3.607629,"median":-0.996609,"eighty":-0.830049,"marketCap":74087967},{"date":"2023-07-07","current":-0.78781,"twenty":-3.566382,"median":-0.993208,"eighty":-0.824593,"marketCap":70520769},{"date":"2023-07-14","current":-0.815398,"twenty":-3.536514,"median":-0.99316,"eighty":-0.822592,"marketCap":72990368},{"date":"2023-07-21","current":-0.842987,"twenty":-3.522291,"median":-0.989806,"eighty":-0.82124,"marketCap":75459967},{"date":"2023-07-28","current":-0.849118,"twenty":-3.486734,"median":-0.985931,"eighty":-0.822592,"marketCap":76008766},{"date":"2023-08-04","current":-0.842987,"twenty":-3.454022,"median":-0.985458,"eighty":-0.822602,"marketCap":75459967},{"date":"2023-08-11","current":-0.873641,"twenty":-3.441984,"median":-0.980924,"eighty":-0.823797,"marketCap":78203965},{"date":"2023-08-18","current":-0.878604,"twenty":-3.372515,"median":-0.979241,"eighty":-0.82539,"marketCap":74028579},{"date":"2023-08-25","current":-0.940627,"twenty":-3.299607,"median":-0.975457,"eighty":-0.826964,"marketCap":79254417},{"date":"2023-09-01","current":-0.937361,"twenty":-3.233197,"median":-0.973023,"eighty":-0.82766,"marketCap":78979228},{"date":"2023-09-08","current":-0.885104,"twenty":-3.159567,"median":-0.971728,"eighty":-0.82766,"marketCap":74576205},{"date":"2023-09-15","current":-0.829581,"twenty":-2.981269,"median":-0.970062,"eighty":-0.826617,"marketCap":69897993},{"date":"2023-09-22","current":-0.76426,"twenty":-2.79503,"median":-0.966806,"eighty":-0.822588,"marketCap":64394214},{"date":"2023-09-29","current":-0.70547,"twenty":-2.766156,"median":-0.965603,"eighty":-0.816906,"marketCap":59440813},{"date":"2023-10-06","current":-0.646681,"twenty":-2.727897,"median":-0.962595,"eighty":-0.815979,"marketCap":54487412},{"date":"2023-10-13","current":-0.604222,"twenty":-2.71346,"median":-0.962532,"eighty":-0.812453,"marketCap":50909955},{"date":"2023-10-20","current":-0.636883,"twenty":-2.666539,"median":-0.960045,"eighty":-0.808397,"marketCap":53661845},{"date":"2023-10-27","current":-0.679342,"twenty":-2.665096,"median":-0.95957,"eighty":-0.806065,"marketCap":57239301},{"date":"2023-11-03","current":-0.816517,"twenty":-2.648493,"median":-0.95748,"eighty":-0.802222,"marketCap":68797237},{"date":"2023-11-10","current":-0.522571,"twenty":-2.614566,"median":-0.947902,"eighty":-0.798373,"marketCap":44030232},{"date":"2023-11-17","current":-0.442347,"twenty":-2.594354,"median":-0.946599,"eighty":-0.792483,"marketCap":35925248},{"date":"2023-11-24","current":-0.401672,"twenty":-2.584248,"median":-0.945588,"eighty":-0.790684,"marketCap":32621777},{"date":"2023-12-01","current":-0.305101,"twenty":-2.570532,"median":-0.942446,"eighty":-0.788267,"marketCap":24778786},{"date":"2023-12-08","current":-0.311846,"twenty":-2.563314,"median":-0.941074,"eighty":-0.783066,"marketCap":25326611},{"date":"2023-12-15","current":-0.247443,"twenty":-2.556095,"median":-0.940627,"eighty":-0.780271,"marketCap":20096115},{"date":"2023-12-22","current":-0.180091,"twenty":-2.551764,"median":-0.938014,"eighty":-0.774301,"marketCap":14626118},{"date":"2023-12-29","current":-0.193209,"twenty":-2.551764,"median":-0.937361,"eighty":-0.770792,"marketCap":15691487},{"date":"2024-01-05","current":-0.245647,"twenty":-2.547433,"median":-0.936267,"eighty":-0.769457,"marketCap":19950212},{"date":"2024-01-12","current":-0.275645,"twenty":-2.54238,"median":-0.935334,"eighty":-0.766195,"marketCap":22386522},{"date":"2024-01-19","current":-0.233071,"twenty":-2.539492,"median":-0.934949,"eighty":-0.764849,"marketCap":18928889},{"date":"2024-01-26","current":-0.216937,"twenty":-2.534439,"median":-0.93261,"eighty":-0.754249,"marketCap":17618512},{"date":"2024-02-02","current":-0.227106,"twenty":-2.530108,"median":-0.92518,"eighty":-0.752358,"marketCap":18444380},{"date":"2024-02-09","current":-0.203378,"twenty":-2.528664,"median":-0.923284,"eighty":-0.751224,"marketCap":16517355},{"date":"2024-02-16","current":-0.199107,"twenty":-2.525055,"median":-0.920389,"eighty":-0.749014,"marketCap":16170491},{"date":"2024-02-23","current":-0.18643,"twenty":-2.519281,"median":-0.919085,"eighty":-0.746197,"marketCap":15140909},{"date":"2024-03-01","current":-0.240325,"twenty":-2.504121,"median":-0.917067,"eighty":-0.739651,"marketCap":19518008},{"date":"2024-03-08","current":-0.270832,"twenty":-2.496181,"median":-0.915351,"eighty":-0.735638,"marketCap":21995611},{"date":"2024-03-15","current":-0.219174,"twenty":-2.466585,"median":-0.913491,"eighty":-0.731225,"marketCap":17800203},{"date":"2024-03-22","current":-0.238122,"twenty":-2.421829,"median":-0.911599,"eighty":-0.715205,"marketCap":19339070},{"date":"2024-03-28","current":-0.216598,"twenty":-2.392955,"median":-0.911029,"eighty":-0.70547,"marketCap":17590983},{"date":"2024-04-05","current":-0.545745,"twenty":-2.180008,"median":-0.910426,"eighty":-0.68914,"marketCap":41697098},{"date":"2024-04-12","current":-0.613532,"twenty":-2.057292,"median":-0.907037,"eighty":-0.679342,"marketCap":46876301},{"date":"2024-04-19","current":-0.577442,"twenty":-1.858781,"median":-0.904632,"eighty":-0.663875,"marketCap":44118872},{"date":"2024-04-26","current":-0.455638,"twenty":-1.793814,"median":-0.901286,"eighty":-0.653213,"marketCap":34812547},{"date":"2024-05-03","current":-0.507198,"twenty":-1.570039,"median":-0.897996,"eighty":-0.636883,"marketCap":38751930},{"date":"2024-05-10","current":-0.608637,"twenty":-1.534961,"median":-0.892115,"eighty":-0.623819,"marketCap":46502316},{"date":"2024-05-17","current":-0.561705,"twenty":-1.473562,"median":-0.887764,"eighty":-0.608637,"marketCap":39859128},{"date":"2024-05-24","current":-0.556504,"twenty":-1.454542,"median":-0.885503,"eighty":-0.604222,"marketCap":39490062},{"date":"2024-05-31","current":-0.483742,"twenty":-1.448767,"median":-0.881558,"eighty":-0.597071,"marketCap":34326828},{"date":"2024-06-07","current":-0.53057,"twenty":-1.404749,"median":-0.876706,"eighty":-0.586439,"marketCap":37649763},{"date":"2024-06-14","current":-0.546175,"twenty":-1.387604,"median":-0.876079,"eighty":-0.580482,"marketCap":38757109},{"date":"2024-06-21","current":-0.496031,"twenty":-1.379022,"median":-0.873673,"eighty":-0.570621,"marketCap":35198837},{"date":"2024-06-28","current":-0.488956,"twenty":-1.374775,"median":-0.873641,"eighty":-0.569679,"marketCap":34696841},{"date":"2024-07-05","current":-0.448904,"twenty":-1.357353,"median":-0.873641,"eighty":-0.561773,"marketCap":31854652},{"date":"2024-07-12","current":-0.520114,"twenty":-1.333588,"median":-0.87282,"eighty":-0.555857,"marketCap":36907841},{"date":"2024-07-15","current":-0.53057,"twenty":-1.329066,"median":-0.872339,"eighty":-0.554184,"marketCap":37649763},{"date":"2024-08-02","current":-0.494158,"twenty":-1.324544,"median":-0.872339,"eighty":-0.551376,"marketCap":35065956},{"date":"2024-08-09","current":-0.483847,"twenty":-1.311037,"median":-0.871537,"eighty":-0.546175,"marketCap":31707006},{"date":"2024-08-16","current":-0.556692,"twenty":-1.27492,"median":-0.868973,"eighty":-0.546175,"marketCap":36480567},{"date":"2024-08-23","current":-0.597874,"twenty":-1.27323,"median":-0.865924,"eighty":-0.546175,"marketCap":39179250},{"date":"2024-08-30","current":-0.538985,"twenty":-1.267697,"median":-0.863468,"eighty":-0.546175,"marketCap":35320221},{"date":"2024-09-06","current":-0.518595,"twenty":-1.264807,"median":-0.862048,"eighty":-0.54616,"marketCap":33984066},{"date":"2024-09-13","current":-0.549985,"twenty":-1.263703,"median":-0.858314,"eighty":-0.545667,"marketCap":36041042},{"date":"2024-09-20","current":-0.524699,"twenty":-1.232207,"median":-0.857152,"eighty":-0.544779,"marketCap":34384033},{"date":"2024-09-27","current":-0.504376,"twenty":-1.201879,"median":-0.854893,"eighty":-0.540606,"marketCap":33052273},{"date":"2024-10-04","current":-0.486602,"twenty":-1.189844,"median":-0.850349,"eighty":-0.531977,"marketCap":31887532},{"date":"2024-10-11","current":-0.528522,"twenty":-1.186983,"median":-0.849328,"eighty":-0.53057,"marketCap":34634562},{"date":"2024-10-18","current":-0.529863,"twenty":-1.186643,"median":-0.84452,"eighty":-0.530429,"marketCap":34722467},{"date":"2024-10-25","current":-0.62108,"twenty":-1.173809,"median":-0.842987,"eighty":-0.530429,"marketCap":40700006},{"date":"2024-10-31","current":-0.918877,"twenty":-1.170289,"median":-0.84264,"eighty":-0.53057,"marketCap":60214912},{"date":"2024-11-08","current":-0.727841,"twenty":-1.17008,"median":-0.842987,"eighty":-0.53057,"marketCap":45710590},{"date":"2024-11-15","current":-0.669964,"twenty":-1.168468,"median":-0.840267,"eighty":-0.53057,"marketCap":42075719},{"date":"2024-11-22","current":-0.643941,"twenty":-1.163546,"median":-0.839921,"eighty":-0.531625,"marketCap":40441428},{"date":"2024-11-29","current":-0.76293,"twenty":-1.160538,"median":-0.835323,"eighty":-0.532657,"marketCap":47914300},{"date":"2024-12-06","current":-0.734933,"twenty":-1.159035,"median":-0.830725,"eighty":-0.534491,"marketCap":46155977},{"date":"2024-12-13","current":-0.720934,"twenty":-1.15649,"median":-0.82862,"eighty":-0.53653,"marketCap":45276816},{"date":"2024-12-20","current":-0.65654,"twenty":-1.152,"median":-0.82766,"eighty":-0.53657,"marketCap":41232673},{"date":"2024-12-27","current":-0.682437,"twenty":-1.147776,"median":-0.825921,"eighty":-0.53657,"marketCap":42859122},{"date":"2025-01-03","current":-0.748931,"twenty":-1.14627,"median":-0.822602,"eighty":-0.53657,"marketCap":47035139},{"date":"2025-01-10","current":-0.783928,"twenty":-1.145209,"median":-0.822578,"eighty":-0.537107,"marketCap":49233042},{"date":"2025-01-17","current":-0.797927,"twenty":-1.143284,"median":-0.817491,"eighty":-0.538636,"marketCap":50112204},{"date":"2025-01-24","current":-0.580737,"twenty":-1.142869,"median":-0.816517,"eighty":-0.540201,"marketCap":36472013},{"date":"2025-01-31","current":-0.486385,"twenty":-1.140266,"median":-0.816335,"eighty":-0.53657,"marketCap":30546465},{"date":"2025-02-07","current":-0.482956,"twenty":-1.13297,"median":-0.815659,"eighty":-0.532822,"marketCap":30331071},{"date":"2025-02-14","current":-0.902917,"twenty":-1.125202,"median":-0.815429,"eighty":-0.53057,"marketCap":56705915},{"date":"2025-02-21","current":-0.771637,"twenty":-1.122495,"median":-0.815398,"eighty":-0.531274,"marketCap":48461135},{"date":"2025-02-28","current":-0.649413,"twenty":-1.121121,"median":-0.810785,"eighty":-0.532657,"marketCap":40785074},{"date":"2025-03-07","current":-0.678968,"twenty":-1.117838,"median":-0.809202,"eighty":-0.534491,"marketCap":42641227},{"date":"2025-03-14","current":-0.710276,"twenty":-1.115867,"median":-0.80603,"eighty":-0.53653,"marketCap":41367199},{"date":"2025-03-21","current":-0.696942,"twenty":-1.110216,"median":-0.804926,"eighty":-0.53657,"marketCap":40590594},{"date":"2025-03-28","current":-0.648849,"twenty":-1.102052,"median":-0.802148,"eighty":-0.53657,"marketCap":37789636},{"date":"2025-04-04","current":-0.622447,"twenty":-1.09797,"median":-0.800186,"eighty":-0.536838,"marketCap":36251956},{"date":"2025-04-11","current":-0.588045,"twenty":-1.090488,"median":-0.797927,"eighty":-0.537939,"marketCap":34248313},{"date":"2025-04-17","current":-0.67374,"twenty":-1.087559,"median":-0.796877,"eighty":-0.53939,"marketCap":39239300},{"date":"2025-04-25","current":-0.744946,"twenty":-1.083536,"median":-0.792483,"eighty":-0.541079,"marketCap":43386374},{"date":"2025-05-02","current":-0.671162,"twenty":-1.080126,"median":-0.792322,"eighty":-0.54163,"marketCap":39089156},{"date":"2025-05-09","current":-0.686464,"twenty":-1.071492,"median":-0.790557,"eighty":-0.542848,"marketCap":37277076},{"date":"2025-05-16","current":-0.762738,"twenty":-1.071492,"median":-0.789848,"eighty":-0.543277,"marketCap":41418973},{"date":"2025-05-23","current":-0.855362,"twenty":-1.060555,"median":-0.79216,"eighty":-0.543653,"marketCap":46448698},{"date":"2025-05-30","current":-0.919156,"twenty":-1.057834,"median":-0.792483,"eighty":-0.545155,"marketCap":49912932},{"date":"2025-06-06","current":-0.646814,"twenty":-1.056958,"median":-0.792322,"eighty":-0.545357,"marketCap":35123915},{"date":"2025-06-13","current":-0.651868,"twenty":-1.053301,"median":-0.790557,"eighty":-0.545745,"marketCap":35398361},{"date":"2025-06-20","current":-0.629935,"twenty":-1.051485,"median":-0.788953,"eighty":-0.546031,"marketCap":34207369},{"date":"2025-06-27","current":-0.647958,"twenty":-1.04831,"median":-0.786803,"eighty":-0.54616,"marketCap":35186054},{"date":"2025-07-03","current":-0.665599,"twenty":-1.044442,"median":-0.783892,"eighty":-0.546175,"marketCap":36144026},{"date":"2025-07-11","current":-0.709368,"twenty":-1.041423,"median":-0.782539,"eighty":-0.546175,"marketCap":38520832},{"date":"2025-07-18","current":-0.691346,"twenty":-1.040286,"median":-0.782066,"eighty":-0.546328,"marketCap":37542147},{"date":"2025-07-25","current":-0.658066,"twenty":-1.038426,"median":-0.77892,"eighty":-0.547154,"marketCap":35734946},{"date":"2025-08-01","current":-0.618683,"twenty":-1.036513,"median":-0.775821,"eighty":-0.549045,"marketCap":33596338},{"date":"2025-08-08","current":-0.624977,"twenty":-1.034776,"median":-0.772918,"eighty":-0.549985,"marketCap":33938101},{"date":"2025-08-15","current":-0.670671,"twenty":-1.032863,"median":-0.770792,"eighty":-0.55082,"marketCap":36419472},{"date":"2025-08-22","current":-0.617635,"twenty":-1.031209,"median":-0.769929,"eighty":-0.551376,"marketCap":34724699},{"date":"2025-08-29","current":-0.636533,"twenty":-1.030623,"median":-0.769394,"eighty":-0.551376,"marketCap":35787171},{"date":"2025-09-05","current":-0.661884,"twenty":-1.029262,"median":-0.768301,"eighty":-0.552107,"marketCap":37212439},{"date":"2025-09-12","current":-0.67267,"twenty":-1.026894,"median":-0.765733,"eighty":-0.553877,"marketCap":37818825},{"date":"2025-09-19","current":-0.703736,"twenty":-1.026191,"median":-0.764997,"eighty":-0.555533,"marketCap":39565426},{"date":"2025-09-26","current":-0.699864,"twenty":-1.025051,"median":-0.763296,"eighty":-0.556579,"marketCap":39347749},{"date":"2025-10-03","current":-0.737475,"twenty":-1.02382,"median":-0.763296,"eighty":-0.557899,"marketCap":41462328},{"date":"2025-10-10","current":-0.772782,"twenty":-1.023522,"median":-0.763296,"eighty":-0.560508,"marketCap":43447336},{"date":"2025-10-17","current":-0.698758,"twenty":-1.022012,"median":-0.76293,"eighty":-0.561705,"marketCap":39285555},{"date":"2025-10-24","current":-0.712693,"twenty":-1.020384,"median":-0.762738,"eighty":-0.561728,"marketCap":40069009},{"date":"2025-10-31","current":-0.74083,"twenty":-1.020145,"median":-0.759092,"eighty":-0.56177,"marketCap":41650949},{"date":"2025-11-07","current":-0.766643,"twenty":-1.018727,"median":-0.758032,"eighty":-0.56383,"marketCap":43102202},{"date":"2025-11-14","current":-0.646705,"twenty":-1.01548,"median":-0.755931,"eighty":-0.567511,"marketCap":36359060},{"date":"2025-11-21","current":-0.673208,"twenty":-1.013175,"median":-0.755835,"eighty":-0.569049,"marketCap":39375246},{"date":"2025-11-28","current":-0.68003,"twenty":-1.012814,"median":-0.754068,"eighty":-0.569994,"marketCap":39774248},{"date":"2025-12-05","current":-0.665129,"twenty":-1.01116,"median":-0.753333,"eighty":-0.570308,"marketCap":38902743},{"date":"2025-12-12","current":-0.637573,"twenty":-1.010305,"median":-0.752358,"eighty":-0.571566,"marketCap":37290982}],"updateTime":1765820670882},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572504181","title":"Xilio Therapeutics - Transfers Listing of Co's Common Stock to Nasdaq Capital Market,Effective October 6 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572504181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572504181?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:34","pubTimestamp":1759491254,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nFWN3VJ0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2572504919","title":"Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2572504919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572504919?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:30","pubTimestamp":1759491048,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Transfers to Nasdaq Capital Market After Failing to Meet Minimum Bid Price Requirement; Granted Additional 180 Days to Regain Compliance. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL48Sb1l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2566765691","title":"BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2566765691","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566765691?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:37","pubTimestamp":1757417834,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Starts Phase 2 Trial for XTX301, Hits $17.5M Milestone in Gilead License DealSept 9 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS ANNOUNCES INITIATION OF PHASE 2 TRIAL FOR EF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA6RSKMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2566279691","title":"Xilio Therapeutics Extends Cash Runway into Q1 2027 Following $17.5 Million Milestone Achievement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566279691","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566279691?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:30","pubTimestamp":1757417427,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics, Inc., a clinical-stage biotechnology company, has provided financial guidance indicating a solid cash position. As of June 30, 2025, the company reported cash and cash equivalents totaling $121.6 million. With the recent achievement of a $17.5 million development milestone under its license agreement with Gilead Sciences, Inc., Xilio anticipates that this financial reserve will support its operating expenses and capital expenditure needs into the first quarter of 2027. The company expects to receive the payment for the milestone by the fourth quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDLb5cVx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU0889565916.HKD","XLO","LU1778281490.HKD","BK4585","LU2087621335.USD","LU0114720955.EUR","IE00B64PRP62.GBP","LU0109394709.USD","GILD","IE00B19Z3B42.SGD","LU2324357040.USD","LU2089984988.USD","LU0882574055.USD","IE0002270589.USD","LU2468319806.SGD","IE00B19Z3581.USD","BK4139","IE00BGHQF748.EUR","LU0058720904.USD","LU1430594728.SGD","BK4112","IE00BSNM7G36.USD","LU0823416689.USD","BK4532","LU2210150020.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","SG9999015945.SGD","LU2210149790.SGD","NDAQ","IE00BZ1G4Q59.USD","LU1066051498.USD","BK4583","IE00BKPKM429.USD","BK4578","LU1674673691.USD","LU1839511570.USD","LU1674673428.USD","LU0314104364.USD","BK4550","IE00BKVL7J92.USD","BK4568","SG9999015986.USD","BK4588","IE00B3QW5Z07.USD","SG9999015978.USD","LU0320765992.SGD","LU1066053197.SGD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2563066575","title":"Xilio Therapeutics Inc. Faces Nasdaq Delisting Risk Due to Stockholders' Equity and Minimum Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066575","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563066575?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:06","pubTimestamp":1756411573,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has announced that it received a deficiency letter from the Nasdaq Stock Market on August 22, 2025, indicating non-compliance with the Nasdaq Global Select Market's requirement to maintain a minimum of $10 million in stockholders' equity. The company's equity was reported at $7,069,000 as of June 30, 2025. This follows an earlier notice in April 2025 regarding failure to maintain a $1.00 minimum bid price for its shares. Xilio has until October 6, 2025, to submit a compliance plan, with potential for a 180-day extension if the plan is accepted. The company is exploring options to address these issues, which currently have no immediate effect on its stock listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL2H58w9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2559952623","title":"Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952623","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952623?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:22","pubTimestamp":1755174167,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryXilio Therapeutics Inc XLO.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter ended June","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL8N3U60VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO"],"gpt_icon":0},{"id":"2559269951","title":"BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559269951","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559269951?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171046,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Q2 Net Income USD -15.844 Million\n\n\nAug 14 (Reuters) - Xilio Therapeutics Q2 operating expenses USD 22.45 million.\n\nQ2 basic EPS USD -0.16\nQ2 income from operations USD -14.366 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLXA29882:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2559514219","title":"Xilio Therapeutics Reports Q2 2025 Results: Collaboration and License Revenue Surges to $8.1M; Net Loss Widens to $15.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2559514219","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559514219?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171043,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL2BPFG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","NDAQ","XLO","GILD"],"gpt_icon":0},{"id":"2559951754","title":"Xilio Therapeutics Inc: on Track to Nominate First Development Candidates for Wholly Owned Masked T Cell Engager Programs in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559951754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559951754?lang=en_us&edition=fundamental","pubTime":"2025-08-14 19:30","pubTimestamp":1755171001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLXA29882:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2557301717","title":"Xilio Therapeutics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557301717?lang=en_us&edition=fundamental","pubTime":"2025-08-07 03:06","pubTimestamp":1754507160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XLO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 06, 2025 15:06 ET (19:06 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","LENZ"],"gpt_icon":0},{"id":"2557379685","title":"Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2557379685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557379685?lang=en_us&edition=fundamental","pubTime":"2025-08-06 19:38","pubTimestamp":1754480288,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Xilio Therapeutics at Outperform With $2 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","XLO"],"gpt_icon":0},{"id":"2556538928","title":"Catalyst Pharmaceuticals Appoints Daniel Curran, Md, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2556538928","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556538928?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:03","pubTimestamp":1754308980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA1ZCDWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO","IE0034390439.USD","IE00B19Z6F94.USD","CPRX"],"gpt_icon":0},{"id":"2556338933","title":"Xilio Therapeutics Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338933","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556338933?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:50","pubTimestamp":1754308204,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc  expected to post a loss of10cents a share - Earnings Preview Xilio Therapeutics Inc XLO.OQ XLO.O is expected to  show a rise in quarterly revenue when it reports  results on Au","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW0TO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO"],"gpt_icon":0},{"id":"2556845799","title":"Xilio Therapeutics Unveils New Stock Option Grants for Employees Under 2022 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2556845799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556845799?lang=en_us&edition=fundamental","pubTime":"2025-08-02 04:30","pubTimestamp":1754080209,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Aug. 01, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company, announced the granting of non-qualified stock options to purchase 134,000 shares of its common stock to two new employees under its 2022 Inducement Stock Incentive Plan. The stock options have an exercise price of $0.65 per share, reflecting the closing price on August 1, 2025. Each option has a ten-year term, with 25% vesting on the first anniversary of employment commencement and the remaining 75% vesting in 36 equal monthly installments, contingent on continued service. These grants comply with Nasdaq Listing Rule 5635.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL7bCPhh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","LU2095319765.USD","BK4139","LU2210149790.SGD","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2544880731","title":"Director Shannon James Samuel Reports Acquisition of Common Shares in Xilio Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2544880731","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544880731?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:57","pubTimestamp":1750280275,"startTime":"0","endTime":"0","summary":"James Samuel Shannon, a director at Xilio Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDLbtRrgP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2544188075","title":"Rene Russo, President and CEO, Reports Acquisition of Common Shares in Xilio Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2544188075","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544188075?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:57","pubTimestamp":1750280232,"startTime":"0","endTime":"0","summary":"Rene Russo, President and CEO of Xilio Therapeutics Inc., reported an acquisition of common shares of Xilio Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL26k38S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rene Russo, President and CEO, Reports Acquisition of Common Shares in Xilio Therapeutics Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2543475935","title":"Xilio Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Bello Akintunde Olatokumbo","url":"https://stock-news.laohu8.com/highlight/detail?id=2543475935","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543475935?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:34","pubTimestamp":1749760471,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has filed an initial statement of beneficial ownership. The filing identifies Bello Akintunde Olatokumbo as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDLNtZsD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2543473665","title":"Xilio Therapeutics Inc. Held Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543473665","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543473665?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:31","pubTimestamp":1749760266,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. held its annual meeting of stockholders on June 10, 2025. During the meeting, stockholders elected René Russo, Pharm.D., Sara M. Bonstein, and James Shannon, M.D., as Class I directors. An amendment to increase the total number of authorized shares of common stock from 200,000,000 to 600,000,000 was approved. Additionally, an amendment to the Certificate of Incorporation regarding officer exculpation was approved. The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Elect","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL1vFQ5c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2542083347","title":"Xilio Therapeutics Appoints Dr. Akintunde Bello to Board of Directors, Enhancing Leadership in Cancer Immunotherapy Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2542083347","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542083347?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:30","pubTimestamp":1749587410,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Appoints Dr. Akintunde Bello to Board of Directors, Enhancing Leadership in Cancer Immunotherapy Development. Xilio Therapeutics, Inc. has announced the appointment of Akintunde  Bello, Ph.D., to its board of directors. Dr. Bello brings over 25 years of experience in oncology drug development, having previously held senior positions at Bristol Myers Squibb and Pfizer. His expertise is expected to support Xilio's advancement in developing tumor-activated immuno-oncology therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL6RxYvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU0170899867.USD","LU1066053197.SGD","IE0002141913.USD","IE00BLSP4239.USD","LU1868837300.USD","LU0114720955.EUR","LU0306806265.USD","LU1291159041.SGD","LU1868837136.USD","IE00BBT3K403.USD","LU1585245621.USD","LU2125154778.USD","NDAQ","LU0985481810.HKD","BK4550","IE00B19Z3581.USD","IE00BJT1NW94.SGD","SG9999002232.USD","LU1868836757.USD","SG9999013999.USD","LU1670711040.USD","LU0289739699.SGD","LU1670711123.USD","LU1718418525.SGD","IE00B64PRP62.GBP","LU0306807586.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","LU0237698245.USD","SGXZ57979304.SGD","LU1066051498.USD","BK4581","IE00B3QW5Z07.USD","BMY","LU0096364046.USD","LU0456855351.SGD","LU1670710588.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0061475181.USD","IE0009355771.USD","XLO","LU1883839398.USD","IE00BLSP4452.SGD","LU1894683348.USD","SG9999001176.SGD","BK4112"],"gpt_icon":1},{"id":"2540702502","title":"Xilio Therapeutics Announces New Stock Option Grants for Employees Under 2022 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2540702502","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540702502?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:30","pubTimestamp":1748982621,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., June 03, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company, has announced the grant of non-qualified stock options to purchase 181,300 shares of its common stock to five new employees under its 2022 Inducement Stock Incentive Plan, effective June 1, 2025. The stock options carry an exercise price of $1.07 per share, matching the closing price of the company's stock on May 30, 2025. Each option has a ten-year term, with 25% vesting after one year of service and the remaining 75% vesting in 36 monthly installments, contingent upon continued employment. These grants comply with Nasdaq Listing Rule 5635.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL7rSRpC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4139","BK4585","XLO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}]}}